title: Contrasting effects of basic fibroblast growth factor and neurotrophin 3 on cell cycle kinetics of mouse cortical stem cells.
abstract: Basic fibroblast growth factor (bFGF) exerts a mitogenic effect on cortical neuroblasts, whereas neurotrophin 3 (NT3) promotes differentiation in these cells. Here we provide evidence that both the mitogenic effect of bFGF and the differentiation-promoting effect of NT3 are linked with modifications of cell cycle kinetics in mouse cortical precursor cells. We adapted an in vitro assay, which makes it possible to evaluate (1) the speed of progression of the cortical precursors through the cell cycle, (2) the duration of individual phases of the cell cycle, (3) the proportion of proliferative versus differentiative divisions, and (4) the influence on neuroglial differentiation. Contrary to what has been claimed previously, bFGF promotes proliferation via a change in cell cycle kinetics by simultaneously decreasing G1 duration and increasing the proportion of proliferative divisions. In contrast, NT3 lengthens G1 and promotes differentiative divisions. We investigated the molecular foundations of these effects and show that bFGF downregulates p27(kip1) and upregulates cyclin D2 expression. This contrasts with NT3, which upregulates p27(kip1) and downregulates cyclin D2 expression. Neither bFGF nor NT3 influences the proportion of glia or neurons in short to medium term cultures. The data point to links between the length of the G1 phase and the type of division of cortical precursors: differentiative divisions are correlated with long G1 durations, whereas proliferative divisions correlate with short G1 durations. The present results suggest that concerted mechanisms control the progressive increase in the cell cycle duration and proportion of differentiative divisions that is observed as corticogenesis proceeds.
authors.affiliation: Institut National de la Santé et de la Recherche Médicale U371, Cerveau et Vision, 69675 Bron, France.
authors.forename: Agnès
authors.initials: A
authors.lastname: Lukaszewicz
authors.forename: Pierre
authors.initials: P
authors.lastname: Savatier
authors.forename: Véronique
authors.initials: V
authors.lastname: Cortay
authors.forename: Henry
authors.initials: H
authors.lastname: Kennedy
authors.forename: Colette
authors.initials: C
authors.lastname: Dehay
mesh_terms: D000818:Animals; D001973:Bromodeoxyuridine; D002453:Cell Cycle / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000166:cytology / Q000187:drug effects* / Q000196:embryology; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology*; D016193:G1 Phase / Q000187:drug effects; D017930:Genes, Reporter; D005904:Glial Fibrillary Acidic Protein / Q000096:biosynthesis; D007150:Immunohistochemistry; D051379:Mice; D008822:Mice, Transgenic; D018715:Microscopy, Video / Q000379:methods; D008869:Microtubule-Associated Proteins / Q000096:biosynthesis; D020933:Neurotrophin 3 / Q000494:pharmacology*; D018809:Proliferating Cell Nuclear Antigen / Q000096:biosynthesis; D013234:Stem Cells / Q000166:cytology / Q000187:drug effects*; D013997:Time Factors
chemical_list: D005904:Glial Fibrillary Acidic Protein; D008869:Microtubule-Associated Proteins; D020933:Neurotrophin 3; D018809:Proliferating Cell Nuclear Antigen; D016222:Fibroblast Growth Factor 2; D001973:Bromodeoxyuridine